Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
my sources tell me he has. he won't tell a shareholder that. I don't know why he seems to be unfriendly to shareholders. He doesn't release a pr to help the share price either. He needs to feel pressured to help shareholders out. We need IR.
I hope he doesn't walk borderline of a lack of fiduciary duty in the near future if he doesn't pr substantial events like FDA 510k granted. But then again why does he have the twitter set up albeit not doing a good job updating...
Tom hasn't filed the new 510k. That means eons before FDA clearance and boatloads of cash to stay afloat aka dilution city. He doesn't seem to care if pr'ing updates will save the company a couple million market cap
This is correct. The priority is the cash lifeline of convertible note holders not shareholders. Noteholders want the share price on a tight leash for the next round of conversions. The anemic volume is your first clue that the .02 floor break is imminent.
problem is when there is news the company doesn't pr it. even if we get the FDA clearance I am a bit worried if the CEO will pr it. He doesn't seem to care if pr'ing updates will save the company a couple million market cap. An IR fix could mean this is trading at .07 considering where we are
I think we're flying way under the radar.I thinks with any news,this one flys!
soon as news hits----boooomage
looks like rmsl getting accumulated. i increased my position by nearly 50% here. gonna be a huge winner soon. thinking .50-1.00 coming.
thin thin thin will win....once whales come in it will run bigtime...i only have 1k in but could easily become 5k
Yep... remsleeping over here
it will close strong...news hits we go up 100% fast
RMSL opened today at .025 but dropped fast. But I was able to flip & gain shares
zzzzzzzzzzzzzzzzzzzzzzz
The ask to open is .025 maybe a gap up this morning
yup and i bought then at .036 thinking it would go back .047....backfired
RMSL was up over .04 in April. You could have made some $$$’s
i bought .036....hot tip lol
i guess we hear something when they have shares in the system to unload?
You got to be kidding. I’m making money flipping this. If big news comes way up we go.
count me in that lesson 1% who sold 1.6 million shares at .035. again, the reason I announced it is because this stock is worthless and I thought others should know that if you hold this stock for very much longer you will have a big fat zero. IMHO, of course.
Really surprised they haven't PR the fact that they got the patent approved yet... I'm assuming we will see something this week or at least hopeful for it
Where’s the news or at least hearing from RMSL management
LOAD ZONE
Crap, had bids in at $.019 but missed it!
Same...grabbed some at 19
Getting close. Picked up some shares under .02 this morning
I still have that same bid there just incase lol
Maybe another opportunity will come
Had my bid at 0186 but it never filled...wish i had bumped it up a few ticks...oh well woulda, shoulda, coulda...lol
I should of moved fast & picked up some .0186
low volume...thin as f float.....will rebound just as fast
Looks just fine, I'll take some shares before 8k hits. Wouldn't expect news the next day and doubt company wanted to fluff anything near Q and roll out some information in May. GLTA
He was correct about the patent so let’s see what happens with the FDA.
We all know he could clear the FDA question pretty quick with a PR.
If you are long I sincerely hope he comes through for you but he's been making those claims for literally several YEARS. There's a 2017 PR that says they were taking pre-orders of the DeltaWave on the old website.
He also stated a few months back that he hoped to be selling mask in April. So he was right about patent and behind with FDA approval.
The chart tells the story. It was left for dead because both the 510k and patent were rejected around November beating it down to trips, low dubs. The patent was revived and that's what gave it a boost.
They can't sell the product without FDA clearance. That's critical information that shareholders and new investors have the right to know.
It's dead money waiting for the 510k approval which could take many months to years.
The CEO tweeted several weeks back that patent would be issued, but strange he does not PR it when it does get granted. I like several others have emailed him re PR of patent and update re FDA. There is no doubt that patent was important, but FDA approval is what sends share price way higher, just need update as to where we are in this process, from previous tweets by CEO, we should be close.
SO BUY ON RUMOR SELL ON NEWS?
Yes but they pre-announced it on their Twitter a few weeks ago that it would be approved 4/27.
in at .0036 ..do you see it going back anytime soon? i was sure it would today on 4/27 patent issue DD
Looks healthy from .0038 when I charted this ticker and a friend alerted me before most was here posting. All ihub sentiments are funny, as if big money relies on ihub. GLTA
says it was issued 4/27?
Patent news was baked for weeks.
They announced it on their Twitter account 4/08. Not news to anyone at this point.
GREAT NEWS WITH PATENT ISSUED 4/27 AND WE WENT RED :(
WELCOME TO THE OTC SEWERS
Was able to grab a few more on that dip, just need Tom to release that PR.
Was just going to say thanks for the dip on BS posts lmfao. I'll take it, seen MM's come in market at 2:55 stealing money. I slapped some again, while some try to confuse a small amount of traders. GLTY
Followers
|
312
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31325
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |